Sweet and sour recipes for the brain 4. “Physiological” concentrations: what and where?

What concentrations are physiological and what are not (usually called pharmacological)? The physiological ones  normally refer to the levels of a substance relevant to the naturally occurring, which, logically, for neurons is the milieu they strive in. It is called extracellular fluid (ECF) and is notorious for dramatic differences with not only blood (plasma) but even with the cerebrospinal fluid (CSF).

“Importantly, microdialysis data have shown that both in adult humans and in rats,the basal glucose levels are about 1–2 mM in the ECF of the neocortex and hippocampus [32,33,37,38] compared with 5–7 mM in the blood, whereas concentrations of lactate are about 2–5 mM in the ECF [32,34,39,40] compared with 1–2 mM in the adult blood.” (Zilberter et al., 2010). The authors further stressed the imperative of providing adequate means for energy substrates to be utilized in the artificial milieu, in which brain slices are placed:

“In brain slices, energy deficiency cannot be managed in the same way as in whole-body homeostasis, resulting in higher ES levels in  slices than in vivo. The importance of a proper oxygen supply should be stressed [55], because oxidative phosphorylation is proportional to the presence of O2. Therefore, at an inadequate oxygen level, the efficacy of ES might be negligible. It is not surprising that energy metabolism in slices differs from that occurring in the living brain, and is probably impaired [52–54].”

Khakhalin (2011) wrote in his recent review that effects of ES on GABA action has been shown for “…4-5  mM concentrations of beta-hydroxybutyrate  (Rheims et al. 2009), lactate and pyruvate (Holmgren et al. 2010), and was later confirmed by independent research groups for similar concentrations of pyruvate (Tyzio et al. 2011), and lactate (Ruusuvuori et al. 2010).” He continued arguing whether  the concentrations were  ”physiological ” in the experiments showing equal results in different authors who made, however, different conclusions: Tyzio et al. state that the physiological concentration of pyruvate is 1.6 – the one they measured in plasma.

“This comparison may be not valid, however, as it is well known from microdialysis studies that the extracellular fluid, immediately surrounding neural cells, differs in its composition not only from the blood plasma, but even from the cerebrospinal fluid. In particular, concentration of lactate in the extracellular fluid of rats and humans was found to be 2-5 times higher than in the blood plasma… 4-5 mM concentrations are likely to be physiologically relevant… On the other hand, at these concentrations both lactate and pyruvate induce noticeable changes in GABA- and glutamatergic transmission in developing neural networks. It means that some changes in experimental protocols and related theoretical paradigms may still be necessary.”

Kasischke (2011) in his comment on the article by Ivanov et al., 2011, wrote: “From the very beginning, the authors took great care to ensure both viability and functionality of their preparations.”

“An important implication of this methodological tour de force is that under many previously reported experiments the requirements for viability may been met while the functionality may have been compromised.”

References

 

  1. Zilberter Y, Zilberter T, Bregestovski P. (2010) Neuronal activity in vitro and the in vivo reality: the role of energy homeostasis. Trends Pharmacol Sci., 31(9):394-401
  2. [32,33,3437,38,39,40,52-55]  are cited in Zilberter et al. (2010)
  3. Khakhalin A (May 18, 2011). Questioning the depolarizing effects of GABA during early brain development. J Neurophysiol doi: 0.1152/jn.00293.2011.
  4. Tyzio et al. (2011) and  Ruusuvuori et al. (2010) are cited in Khakhalin ( 2011).
  5. Kasischke K (2011). Lactate fuels the neonatal brain. Frontiers in Neuroenergetics; 3, 4

“Brain metabolism in vitro” and those sour energy substrates

This paper suggests that the developmental switch in the reversal potential for gamma-aminobutyric acid (GABA) is regulated by different energy sources

This paper suggests that the developmental switch in the reversal potential for gamma-aminobutyric acid (GABA) is regulated by different energy sources

An evaluation of our article (1) appeared in the “Faculty of 1000 postpublication peer reviews” the conclusion being:

The findings of Rheims et al. have a potentially major impact on our understanding of GABAergic function during development, bringing back an element of inhibition in developing neuronal networks that appeared to rely entirely on excitatory connections (2).

This article (1) along with the article (3) later became an indirect subject of another evaluation (4) although formally, the evaluation concerned a different paper (5), which has been commended because (the author’s words):

“It settles an important issue related to brain metabolism in vitro and the role of acidification in brain patterns.”

The acidification issue doesn’t seem to be resolved either in 5 nor in 4, so a comment to the evaluation appeared in May 2011,  stating among other things the following:

We showed that inhibition of spontaneous network activity in neonatal hippocampal slices by energy substrates is not correlated with intracellular acidification (7) and that they work altering intrinsic features of energy metabolism namely NAD(P)H and oxygen utilization (8).

Another data challenged in 5 is whether lactate as efficient as an energy substrate: “Lactate is not an efficient replacement for glucose” wrote Dr Ben-Ari and Y. Zilberter in his comment referred to the paper 8 titled “Lactate effectively covers energy demands during neuronal network activity in neonatal hippocampal slices” and the work of Wyss et al. (9) titled “In Vivo Evidence for Lactate as a Neuronal Energy Source”.

References

1. Rheims S, Holmgren CD, Chazal G, Mulder J, Harkany T, Zilberter T, Zilberter Y. (2009) J Neurochem.  Aug;110(4):1330-8. Epub 2009 Jun 22. (on Brain Fuels)

2. Scimemi A, Diamond J: 2009. F1000.com/1166168

3. Holmgren CD, Mukhtarov M, Malkov AE, Popova IY, Bregestovski P, Zilberter Y. (2010) J Neurochem. Feb;112(4):900-12. Epub 2009 Nov 24. (on Brain Fuels)

4. Ben-Ari Y: 2011. F1000.com/6913961

5. Ruusuvuori E, Kirilkin I, Pandya N, Kaila K (2010) J Neurosci.  Nov 17; 30(46):15638-42

6. Zilberter Y, Zilberter T, Bregestovski P. (2010) Trends Pharmacol Sci., 31(9):394-401 (on Brain Fuels)

7. Mukhtarov, M., Ivanov, A., Zilberter, Y., and Bregestovski, P. (2011) J Neurochem 116, 316-321

8. Ivanov A, Mukhtarov M, Bregestovski P and Zilberter Y (2011) Front. Neuroenerg. 3:2.

9. Wyss M, Jolivet R, Buck A, Magistretti P, and Weber B. (2011)  J Neuroscience, 31(20):7477-7485

To leave a comment or question click here